The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Journal: Evidence-based Cardiology. 2013;(3): 16‑20

Read: 1286 times

To cite this article:

. Evidence-based Cardiology. 2013;(3):16‑20. (In Russ.)

References:

  1. Qiu C., Winblacl B., Fratiglioni L. The age-dependent relation of blood pressure to cognitive function and dementia. Lancet Neurol 2005;4:487-499.
  2. Ferri C.P., Prince M., Brayne C., et al. Global prevalence of dementia: a Delphi consensus study. Lancet 2005; 366:2112-2117.
  3. Forette F., Seux M.L., Staessen J.A., et al. Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (SYST-EUR) trial. Lancet 1998; 352:1347-1351.
  4. Starr J.M., Whalley L.J., Deary I.J. The effects of antihypertensive treatment on cognitive function: results from the HOPE study. J Am Geriatr Soc 1996;44:411-415.
  5. Lithell H., Hansson L., Skoog I., et al. The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial. J Hyperens 2003;21:875-886.
  6. Applegate W.B., Pressel S., Wittes J., et al. Impact of the treatment of isolated systolic hypertension on behavioral variables. Results from the systolic hypertension in the elderly program. Arch Intern Med 1994;154:2154-2160.
  7. Peters R., Beckett N., Forette F., el al. Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial Cognitive function assessment (HYVTJT-COG): a double-blind, placebo controlled trial. Lancet Neurol 2008;7:683-689.
  8. Prince M.J., Bird A.S., Blizard R.A., Mann A.H. Is the cognitive function of older patients affected by antihypertensive treatment? Results from 54 months of the Medical Research Council's trial of hypertension in older adults. BMJ 1996;312:801-805.
  9. Birns J., Morris R., Donaldson N., Kalra L. The effects of blood pressure reduction on cognitive function: a review of effects based on pooled data from clinical trials. J Hypertens 2006;24:1907-1914.
  10. Fournier A., Oprisiu-Fournier R., Serot J.M., et al. Prevention of dementia by antihypertensive drugs: how ATl-receptor-blockers and dihydropyridines better prevent dementia in hypertensive patients than thiazides and ACE-inhibitors. Expert Rev Neurother 2009;9:1413-1431.
  11. Lumley T. Network meta-analysis for indirect treatment comparisons. Stat Med 2002;21:2313-2324.
  12. McGuinness B., Todd S., Passmore P., Bullock R. Blood pressure lowering in patients without prior cerebrovascular disease for prevention of cognitive impairment and dementia. Cochrane Database Syst Rev 2009:CD004034.
  13. Anderson C., Teo K., Gao P., et al. Renin-angiotensin system blockade and cognitive function in patients at high risk of cardiovascular disease: analysis of data from the ONTARGET and TRANSCEND studies. Lancet Neurol 2011;10:43-53.
  14. Chang-Quan H., Hui W., Chao-Min W., et al. The association of antihypertensive medication use with risk of cognitive decline and dementia: a meta-analysis of longitudinal studies. Int J Clin Pracl 2011;65:1295-1305.
  15. O'Brien J.T., Erkinjuntti T., Reisberg B., et al. Vascular cognitive impairment. Lancet Neurol 2003;2:89-98.
  16. Erkinjuntti T., Ostbye T., Steenhuis R., Hachinski V. The effect of different diagnostic criteria on the prevalence of dementia. N Engl J Med 1997;337:1667-1674.
  17. Muldoon M.F., Waldstein S.R., Ryan C.M., et al. Effects of six antihypertensive medications on cognitive performance. J Hypertens 2002;20:1643-1652.
  18. Staessen J.A., Thijs L., Richart T., et al. Placebo-controlled trials of blood pressure-lowering therapies for primary prevention of dementia. Hypertension 2011;57:e6-7.
  19. Hanon O., Berrou J.P., Negre-Pages L., et al. Effects of hypertension therapy based on eprosartan on systolic arterial blood pressure and cognitive function: primary results of the observational study on cognitive function and systolic blood pressure reduction open-label study. J Hypertens 2008;26:1642-1650.
  20. Tzourio C., Anderson C., Chapman N., et al. Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease. Arch Intern Med 2003;163:1069-1075.
  21. Takeda S., Sato N., Takeuchi D., el al. Angiotensin receptor blocker prevented beta-amyloid-induced cognitive impairment associated with recovery of neurovascular coupling. Hypertension 2009;54:1345-1352.
  22. Okuyama S., Sakagawa T., Inagami T. Role of the angiotensin II type-2 receptor in the mouse central nervous system. Jpn J Pharmacol 1999;81:259-263.
  23. Wright J.W., Stubley L., Pederson E.S., et al. Contributions of the brain angiotensin IV-AT4 receptor subtype system to spatial learning. J Neurosci 1999;19:3952-3961.
  24. Song F., Altman D.G., Glenny A.M., Deeks J.J. Validity of indirect comparison for estimating efficacy of competing interventions: empirical evidence from published meta-analyses. BMJ 2003;326:472.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.